The Division of Biomarker Research is dedicated to discovering, validating, and translating biological markers that improve cancer detection, prognosis, and treatment response.

Our work bridges basic science and clinical application to enable more accurate and personalized cancer care.

Using state-of-the-art technologies, our researchers identify biomarkers that reveal disease mechanisms, predict therapeutic outcomes, and guide precision medicine strategies. The division also develops robust analytical platforms and collaborates with clinical teams to integrate biomarker findings into patient care and clinical trials.

Through a multidisciplinary approach, the Division of Biomarker Research advances early detection and targeted therapy initiatives, helping transform cancer diagnosis and management for better patient outcomes.